[go: up one dir, main page]

WO2002036760A3 - Methodes d'expression des genes endogenes par integration mediee par enzymes de restriction - Google Patents

Methodes d'expression des genes endogenes par integration mediee par enzymes de restriction Download PDF

Info

Publication number
WO2002036760A3
WO2002036760A3 PCT/US2001/045045 US0145045W WO0236760A3 WO 2002036760 A3 WO2002036760 A3 WO 2002036760A3 US 0145045 W US0145045 W US 0145045W WO 0236760 A3 WO0236760 A3 WO 0236760A3
Authority
WO
WIPO (PCT)
Prior art keywords
restriction enzyme
methods
endogenous genes
expressing endogenous
enzyme mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/045045
Other languages
English (en)
Other versions
WO2002036760A2 (fr
Inventor
Janine Lin
Debbie Yaver
Donald Foster
Richard Holly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Novozymes Inc
Original Assignee
Zymogenetics Inc
Novozymes Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc, Novozymes Biotech Inc filed Critical Zymogenetics Inc
Priority to EP01992773A priority Critical patent/EP1352060A2/fr
Priority to AU2002227069A priority patent/AU2002227069A1/en
Publication of WO2002036760A2 publication Critical patent/WO2002036760A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002036760A3 publication Critical patent/WO2002036760A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des méthodes visant à produire une cellule mammifère mutante par introduction dans des cellules mammifères d'une construction d'acide nucléique et une d'une enzyme de restriction dans des conditions permettant à ladite construction d'acide nucléique de s'intégrer au génome des cellules mammifères sur des sites générés par l'enzyme de restriction.
PCT/US2001/045045 2000-10-30 2001-10-30 Methodes d'expression des genes endogenes par integration mediee par enzymes de restriction Ceased WO2002036760A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01992773A EP1352060A2 (fr) 2000-10-30 2001-10-30 Methodes d'expression des genes endogenes par integration mediee par enzymes de restriction
AU2002227069A AU2002227069A1 (en) 2000-10-30 2001-10-30 Methods for expressing endogenous genes by restriction enzyme mediated integration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70217700A 2000-10-30 2000-10-30
US09/702,177 2000-10-30

Publications (2)

Publication Number Publication Date
WO2002036760A2 WO2002036760A2 (fr) 2002-05-10
WO2002036760A3 true WO2002036760A3 (fr) 2003-08-14

Family

ID=24820153

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/045045 Ceased WO2002036760A2 (fr) 2000-10-30 2001-10-30 Methodes d'expression des genes endogenes par integration mediee par enzymes de restriction

Country Status (3)

Country Link
EP (1) EP1352060A2 (fr)
AU (1) AU2002227069A1 (fr)
WO (1) WO2002036760A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003304710A1 (en) * 2003-05-09 2005-09-01 Codegrok, Inc. Dba Auilix Biopharma Method for identifying cellular targets
CN105101979B (zh) 2012-12-21 2021-10-08 安斯泰来再生医药协会 由多能干细胞制备血小板的方法及其组合物
JPWO2020196742A1 (fr) * 2019-03-28 2020-10-01

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015650A1 (fr) * 1997-09-26 1999-04-01 Athersys, Inc. Expression de genes endogenes par recombinaison non homologue d'une construction vectorielle a l'aide d'adn cellulaire

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015650A1 (fr) * 1997-09-26 1999-04-01 Athersys, Inc. Expression de genes endogenes par recombinaison non homologue d'une construction vectorielle a l'aide d'adn cellulaire

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BRENNEMAN MARK ET AL: "Stimulation of intrachromosomal homologous recombination in human cells by electroporation with site-specific endonucleases.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 93, no. 8, 1996, 1996, pages 3608 - 3612, XP002233940, ISSN: 0027-8424 *
MANIVASAKAM PALANIYANDI ET AL: "Restriction enzymes increase efficiencies of illegitimate DNA integration but decrease homologous integration in mammalian cells.", NUCLEIC ACIDS RESEARCH, vol. 29, no. 23, 1 December 2001 (2001-12-01), December 1, 2001, pages 4826 - 4833, XP002233941, ISSN: 0305-1048 *
SHEMESH M ET AL: "Gene integration into bovine sperm genome and its expression in transgenic offspring.", MOLECULAR REPRODUCTION AND DEVELOPMENT. UNITED STATES JUN 2000, vol. 56, no. 2 Suppl, June 2000 (2000-06-01), pages 306 - 308, XP008014700, ISSN: 1040-452X *
YORIFUJI T ET AL: "CO-TRANSFER OF RESTRICTION ENDONUCLEASES AND PLASMID DNA INTO MAMMALIAN CELLS BY ELECTROPORATION EFFECTS ON STABLE TRANSFORMATION", MUTATION RESEARCH, vol. 243, no. 2, 1990, pages 121 - 126, XP008014769, ISSN: 0027-5107 *

Also Published As

Publication number Publication date
AU2002227069A1 (en) 2002-05-15
WO2002036760A2 (fr) 2002-05-10
EP1352060A2 (fr) 2003-10-15

Similar Documents

Publication Publication Date Title
WO1998012311A3 (fr) Utilisation d'un virus a adn non mammalien pour l'expression d'un gene exogene dans une cellule mammalienne
WO2002077264A3 (fr) Procede de transfection en reseau et utilisation associee
CA2338820A1 (fr) Surexpression de proteines recherchees dans des cellules eucaryotes produite par la surexpression de la cycline d1
NZ333998A (en) Method for reducing expression variability of transgenes in plant cells using DNA constructs comprising insulator elements
WO1999015682A3 (fr) Materiels et procedes destines a rendre silencieux un gene
WO2001090345A3 (fr) Procedes et compositions pour augmenter la liberation d'un acide nucleique dans une cellule
WO2002006457A3 (fr) Genes de lipase
EP0945515A3 (fr) Production de protéines par recombinaison homologue
WO2003062394A3 (fr) Methodes et compositions d'interference arn
WO2004090155A3 (fr) Procedes permettant de produire des substances biologiques dans des mutants de aspergillus niger deficients pour une enzyme
WO2000077233A3 (fr) Virus d'adn non mammalien resistant au complement et utilisations de ces virus
AU5539898A (en) Nucleic acid construct for the cell cycle regulated expression of structural genes
PL326087A1 (en) Improved integration of exogenic dna introduced into eucariotic cells
HK1048650A1 (zh) 在细胞培养物中增强细胞激动素(cytokines)的方法
WO1999060137A3 (fr) Procedes de production de polypeptides heterologues dans des cellules mutantes de champignons filamenteuxdeficientes en trichothecene
WO2002068635A3 (fr) Methodes d'inhibition de l'expression d'un gene cible dans des cellules de mammiferes
WO2003006612A3 (fr) Production de cellules de progeniteurs hematopoietiques transduites
WO2002036760A3 (fr) Methodes d'expression des genes endogenes par integration mediee par enzymes de restriction
WO2006055931A3 (fr) Vecteurs pour expression genique stable
WO2004011609A3 (fr) Methodes de production de substances biologiques dans des mutants deficients en pigment de cellules de bacillus
EP0802258A3 (fr) Procédé de synthèse de polydesoxyribonucléotides, procédé de synthèse d'ADN chromosomique et procédé de production de chromosomes
EP2281892A3 (fr) Procédé de préparer des polypeptides dans de cellules Trichoderma avec des déficiences respiratoires
JP2003511085A5 (fr)
WO2002040629A3 (fr) Promoteurs presentant une specificite pour des cellules endotheliales et leurs procedes d'utilisation
WO2003084479A3 (fr) Procedes de production a grande echelle d'adenovirus et de collections de semence d'adenovirus

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001992773

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001992773

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001992773

Country of ref document: EP